Evolent Health (EVH) Common Equity (2013 - 2026)

Evolent Health's Common Equity history runs 14 years deep, the most recent figure standing at $396.4 million for Q1 2026.

• In Q1 2026, Common Equity fell 57.63% year-over-year to $396.4 million; the TTM figure through Mar 2026 stood at $396.4 million (down 57.63% YoY), while the FY2025 annual figure was $415.2 million, down 58.53% from the prior year.
• Common Equity was $396.4 million for Q1 2026 at Evolent Health, down from $415.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.1 billion in Q1 2023 to a low of $396.4 million in Q1 2026.
• Historically, Common Equity has averaged $879.2 million across 5 years, with a median of $935.5 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Common Equity jumped 83.53% in 2023, then tumbled 58.53% in 2025.
• A 5-year view of Common Equity shows it stood at $859.4 million in 2022, then increased by 24.24% to $1.1 billion in 2023, then fell by 6.22% to $1.0 billion in 2024, then sank by 58.53% to $415.2 million in 2025, then dropped by 4.53% to $396.4 million in 2026.
• The last three Common Equity figures came in at $396.4 million (Q1 2026), $415.2 million (Q4 2025), and $842.2 million (Q3 2025), per Business Quant data.